JP2019534709A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534709A5 JP2019534709A5 JP2019537752A JP2019537752A JP2019534709A5 JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5 JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated polynucleotide
- polynucleotide molecule
- rsv
- protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022144109A JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A JP2025020142A (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662399133P | 2016-09-23 | 2016-09-23 | |
| US62/399,133 | 2016-09-23 | ||
| US201662400476P | 2016-09-27 | 2016-09-27 | |
| US62/400,476 | 2016-09-27 | ||
| PCT/US2017/053047 WO2018057950A1 (en) | 2016-09-23 | 2017-09-22 | Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144109A Division JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019534709A JP2019534709A (ja) | 2019-12-05 |
| JP2019534709A5 true JP2019534709A5 (enExample) | 2020-10-08 |
| JP7198759B2 JP7198759B2 (ja) | 2023-01-04 |
Family
ID=60009756
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537752A Active JP7198759B2 (ja) | 2016-09-23 | 2017-09-22 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2022144109A Active JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A Pending JP2025020142A (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144109A Active JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A Pending JP2025020142A (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10808012B2 (enExample) |
| EP (1) | EP3515930A1 (enExample) |
| JP (3) | JP7198759B2 (enExample) |
| AU (4) | AU2017332789B2 (enExample) |
| WO (1) | WO2018057950A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4190895A1 (en) | 2013-02-08 | 2023-06-07 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| JP7198759B2 (ja) | 2016-09-23 | 2023-01-04 | ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズ | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| US12178869B2 (en) | 2017-12-22 | 2024-12-31 | Codagenix Inc. | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer |
| WO2019172982A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| WO2021231767A1 (en) | 2020-05-13 | 2021-11-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rsv vaccine bearing one or more p gene mutations |
| EP4181956A4 (en) * | 2020-07-16 | 2024-08-07 | Griffith University | VACCINE AGAINST A LIVE ATTENUATED VIRUS |
| EP4319880A4 (en) * | 2021-04-08 | 2025-03-19 | Codagenix Inc. | Method of eliciting an immune response against respiratory syncytial virus |
| WO2025054424A1 (en) * | 2023-09-06 | 2025-03-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human parainfluenza virus immunogenic molecules |
| WO2025128971A1 (en) | 2023-12-14 | 2025-06-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rsv vaccine bearing a polynucleotide which is de-optimised and de-attenuated |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3224404A1 (de) | 1982-06-30 | 1984-01-05 | LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl | Reibungskupplung sowie verfahren zu deren montage |
| US6264957B1 (en) | 1995-09-27 | 2001-07-24 | The United States Of America As Represented By The Department Of Health And Human Services | Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| WO1998002530A1 (en) | 1996-07-15 | 1998-01-22 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| BR9809456B1 (pt) | 1997-05-23 | 2011-06-28 | molécula isolada de polinucleotìdeo, composição de célula ou isenta de célula, partìcula de piv infeciosa, atenuada e imunogênica, e, composição imunogênica. | |
| AU4065500A (en) | 1999-04-13 | 2000-11-14 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| WO2002042326A1 (en) | 2000-11-22 | 2002-05-30 | Biota Scientific Management Pty Ltd | A method of expression and agents identified thereby |
| US7297786B2 (en) | 2004-07-09 | 2007-11-20 | University Of Iowa Research Foundation | RNA interference in respiratory epitheial cells |
| CA2587084C (en) | 2004-10-08 | 2019-07-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Modulation of replicative fitness by using less frequently used synonym ous codons |
| KR101621100B1 (ko) | 2007-03-30 | 2016-05-13 | 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 | 백신에 유용한 약독화 바이러스 |
| US9011876B2 (en) | 2008-11-05 | 2015-04-21 | Merck Sharp & Dohme Corp. | Live, attenuated respiratory syncytial virus |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| EP4190895A1 (en) * | 2013-02-08 | 2023-06-07 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| JP7198759B2 (ja) | 2016-09-23 | 2023-01-04 | ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズ | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
-
2017
- 2017-09-22 JP JP2019537752A patent/JP7198759B2/ja active Active
- 2017-09-22 WO PCT/US2017/053047 patent/WO2018057950A1/en not_active Ceased
- 2017-09-22 US US16/335,099 patent/US10808012B2/en active Active
- 2017-09-22 EP EP17778443.6A patent/EP3515930A1/en active Pending
- 2017-09-22 AU AU2017332789A patent/AU2017332789B2/en active Active
-
2020
- 2020-08-31 US US17/008,025 patent/US11390651B2/en active Active
-
2021
- 2021-08-19 AU AU2021218112A patent/AU2021218112B2/en active Active
-
2022
- 2022-06-28 US US17/851,905 patent/US12054519B2/en active Active
- 2022-09-09 JP JP2022144109A patent/JP7573001B2/ja active Active
- 2022-10-21 AU AU2022256195A patent/AU2022256195B2/en active Active
-
2024
- 2024-06-11 AU AU2024203948A patent/AU2024203948B2/en active Active
- 2024-06-28 US US18/758,660 patent/US20240417431A1/en active Pending
- 2024-10-11 JP JP2024178707A patent/JP2025020142A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019534709A5 (enExample) | ||
| EA202090738A1 (ru) | Способ безопасного индуцирования иммунитета против rsv | |
| JP2016534034A5 (enExample) | ||
| IL276210B2 (en) | Mers-cov vaccine | |
| IL288541B (en) | Vaccine against rsv | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| JP2016539946A5 (enExample) | ||
| JP2018504412A5 (enExample) | ||
| HRP20230694T1 (hr) | Smanjenje ljudskog respiratornog sincicijskog virusa prema ljestvici genoma deoptimizacijom kodon-para | |
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2010508030A5 (enExample) | ||
| JP2016520530A5 (enExample) | ||
| EP2552490A4 (en) | INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF | |
| JP2014527526A5 (enExample) | ||
| FI3511015T9 (fi) | Geneettisesti stabiili elävä heikennetty respiratory syncytial -virusrokote ja sen tuottaminen | |
| KR20120032486A (ko) | 면역화 요법용 발현 벡터로서의 수포성 구내염 바이러스의 상이한 혈청형 | |
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| RU2018112060A (ru) | Слитый белок | |
| JP2015525794A5 (enExample) | ||
| JP2012517239A5 (enExample) | ||
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| JP2018536428A5 (enExample) | ||
| JP2020522249A5 (enExample) | ||
| JP6373601B2 (ja) | アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド | |
| JP2018537103A5 (enExample) |